Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis

BACKGROUND: To assess the outcome of human urinary kallidinogenase (HUK) plus recombinant tissue plasminogen activator (rT-PA) intravenous thrombolysis for stroke patients with an extended time window(4.5 to 9 h). METHODS: A total of 92 acute ischemic stroke patients who fulfilled the criteria were...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xueyuan, Zhang, Xin, Yang, Ying, Wang, Hongzhi, Zhang, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627529/
https://www.ncbi.nlm.nih.gov/pubmed/37247414
http://dx.doi.org/10.1097/NRL.0000000000000499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627529/
https://www.ncbi.nlm.nih.gov/pubmed/37247414
http://dx.doi.org/10.1097/NRL.0000000000000499

Ejemplares similares